Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
Status:
Terminated
Trial end date:
2018-10-19
Target enrollment:
Participant gender:
Summary
There are two parts to this study: the goal of the first part of the study is to find the
best dose of tosedostat when given in combination with capecitabine. The goal of the second
part of the study is to look at how participants respond to treatment with tosedostat and
capecitabine.